314890
Trends and disparities in potentially preventable hospitalizations in non-Hispanic white and black adults in the U.S., 2001-2010
Methods: We used a nationally weighted sample of hospitals from 37 states from the Healthcare Cost and Utilization Project to assess rates of PPHs for acute and chronic illnesses defined by the AHRQ Prevention Quality Indicators for years 2001-2010. Rates of PPHs were calculated using the AHRQ Prevention Quality Indicators.
Results: We observed a decline in PPHs during the study period, yet blacks maintained higher rates of PPHs compared to whites (rate ratio: acute -1.22, chronic – 3.09, overall - 2.18). Rates of PPHs due to acute illnesses declined two-times faster in blacks (Annual %D=-4.58), compared to whites (Annual %D=-2.15). In both races, the highest rates of PPHs occurred among the elderly and patients from rural communities. There was a worsening black-white disparity in large metropolitan areas and among patients from highest income communities. High state-level variation was observed.
Conclusions: The results of this study reveal an overall decline in potentially preventable use of hospital inpatient care, a reverse in the trend from previous decades. Significant black-white disparities persist in rates of PPHs, indicating the need for continued efforts to target clinical and public interventions to address this disparity gap.
Learning Areas:
Chronic disease management and preventionEpidemiology
Program planning
Public health or related research
Learning Objectives:
Describe contemporary trends in potentially preventable hospitalizations including a discussion of the impact of geographic location on racial disparities.
Keyword(s): Health Care Access, Health Disparities/Inequities
Qualified on the content I am responsible for because: I am qualified to be an abstract author because I am fulltime employee at the Agency for Healthcare Research and Quality conducting health services research.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.